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The action of peripherally released leptin at long-form leptin receptors (LepRb) within the brain
represents a fundamental axis in the regulation of energy homeostasis and body weight. Efforts
to delineate the neuronal mediators of leptin action have recently focused on extrahypothalamic
populations and have revealed that leptin action within the nucleus of the solitary tract (NTS) is
critical for normal appetite and body weight regulation. To elucidate the neuronal circuits that
mediate leptin action within the NTS, we employed multiple transgenic reporter lines to charac-
terize the neurochemical identity of LepRb-expressing NTS neurons. LepRb expression was not
detected in energy balance-associated NTS neurons that express cocaine- and amphetamine-reg-
ulated transcript, brain-derived neurotrophic factor, neuropeptide Y, nesfatin, catecholamines,
-aminobutyric acid, prolactin-releasing peptide, or nitric oxide synthase. The population of
LepRb-expressing NTS neurons was comprised of subpopulations marked by a proopiomelano-
cortin-enhanced green fluorescent protein (EGFP) transgene and distinct populations that express
proglucagon and/or cholecystokinin. The significance of leptin action on these three populations
of NTS neurons was assessed in leptin-deficient Ob/Obmice, revealing increased NTS proglucagon
and cholecystokinin, but not proopiomelanocortin, expression. These data provide new insight
into the appetitive brainstem circuits engaged by leptin. (Endocrinology 153: 4600–4607, 2012)
The adipocyte hormone leptin is a critical modulator ofboth acute appetitive state and long-term metabolic
health. Circulating leptin levels correlate with adiposity,
rising with fat accrual and falling with its depletion (1).
Nutritional sufficiency promotes leptin production,
whereas food deprivation decreases leptin release. Further
illustrating leptin’s critical role in energy balance, congen-
ital deficits in leptin signaling in both rodents andhumans,
arising from the genetic abrogation of either the leptin or
leptin receptor (LepR) locus, are associatedwith profound
hyperphagia, morbid obesity,and a consequential decline
in metabolic fitness (1).
Mechanistically, the regulation of acute energy balance
by leptin is contingent upon its action within the central
nervous system and, at the molecular level, specifically at
long-form LepR (LepRb) (2). The most intensely investi-
gated neural pathways directly engaged by leptin lie in the
hypothalamus. Interestingly however, targeted deletions
of distinct hypothalamic LepRb populations (individually
or concertedly) fail to recapitulate the extent of the met-
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Abbreviations: BDNF, Brain-derived neurotrophic factor; CART, cocaine- and amphet-
amine-regulated transcript; CCK, cholecystokinin; ChAT, choline acetyltransferase; EGFP,
enhanced green fluorescent protein; EYFP, enhanced yellow fluorescent protein; GABA,
-aminobutyric acid; GAD67, glutamate decarboxylase-67; GFP, green fluorescent
protein; GLP1, glucagon-like peptide-1; IR, immunoreactive; LepR, leptin receptor; nNOS,
nitric oxide synthase; NPY, neuropeptides Y; NTS, nucleus of the solitary tract; POMC,
proopiomelanocortin; PPG, proglucagon; PrRP, prolactin-releasingpeptide; pSTAT3, phos-
phorylated signal transducer and activator of transcription 3; tdTOM, tdTOMATO; TH,
tyrosine hydroxylase; YFP, yellow fluorescent protein.
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abolic dysfunction andobesity observed of globally LepR-
deficient mice (3–5). These genetic studies suggest critical
roles for extrahypothalamicLepRbpopulations in the reg-
ulation of energy balance by leptin. Indeed, recent inves-
tigations have revealed that leptin action in the nucleus of
the solitary tract (NTS) and the ventral tegmental area
contributes to the regulation of feeding (6–8).
The brainstem NTS represents an integrative node
through which numerous peripherally derived appetitive
signals are routed. Hormonal and mechanical inputs con-
verge within the NTS to regulate the activity of a number
of neurochemically distinct neuronal populations. LepRb-
expressing neuronswithin the caudalNTS aremost abun-
dant in themedial portionat the level of the areapostrema,
an area known to participate in the regulation of appeti-
tive state and consumptive behavior. Brainstem adminis-
tration of exogenous leptin suppressed feeding in rodents
(9). More recently, RNA interference-mediated knock-
down of LepRbmRNAwithin the adult rat NTS and Cre-
mediated ablation of LepRb in the mouse brainstem pro-
moted hyperphagia, accelerated weight gain, and
increased adiposity, revealing the physiological signifi-
cance of this population of LepRb-expressing neurons to
leptin’s energy balance functions (6, 8).
Understanding the NTS systems engaged by leptin that
may be salient to the regulation of appetite and body
weight requires defining their neurotransmitter/neuro-
peptide content. Here we employ multiple transgenic and
histological techniques to reveal the neurochemical phe-
notype of LepRb-expressing neurons within the NTS.
Materials and Methods
Animals
Proopiomelanocortin (POMC)-enhanced green florescent pro-
tein (EGFP) (kindly provided by Profs. Richard Simerly and Mal-
colmLow), neuropeptides Y (NPY)-green florescent protein (GFP)
(kindly provided by Prof. Jeffrey Friedman), proglucagon (PPG)-
yellow fluorescent protein (YFP), LepRb-Cre::enhanced yellow
florescent protein (EYFP) and LepRb-Ires-Cre::tdTOMATO
(tdTOM) (kindly provided by Profs. Joel Elmquist and Jeffrey
Friedman), and cholecystokinin (CCK)-Ires-Cre::EYFP mice were
generated and maintained as previously described (3, 10–13).
Animals were provided with standard laboratory chow and
water ad libitum in a light- and temperature-controlled environ-
ment. POMC-EGFP/LepRb-Ires-Cre::tdTOM and NPY-GFP/
LepRb-Ires-Cre::tdTOM double-reporter lines were generated by
intercrossing homozygote POMC-EGFP or NPY-GFP males with
LepRb-Ires-Cre::tdTOM females. All procedures performed were
in accordance with the United KingdomAnimals (Scientific Proce-
dures) Act, 1986, with appropriate ethical approval (United King-
dom)orNational InstitutesofHealthguidelinesonanimal careand
use andwith the approval of the University Committee onUse and
Care of Animals (United States).
Tissue preparation
Mice were anesthetized with pentobarbitone (50 mg/kg ip)
and transcardially perfused with diethylpyrocarbonate-treated
PBS followed by 10% neutral buffered formalin (Sigma Chem-
ical Co., St. Louis, MO), cryoprotected in 20% sucrose, and
sectioned coronally on a freezing sliding microtome at 25 m.
Dual immunofluorescent histochemistry
As previously described (14), sections were washed in PBS
before blocking in 0.5% BSA/0.5% Triton X-100 in PBS for 1 h
at room temperature. Tissue was incubated overnight at room
temperature in blocking buffer containing the following primary
antibodies (diluted 1/1000): goat -GFP (to detect GFP, EGFP
and EYFP) (Abcam, Cambridge, MA), rabbit -red fluorescent
protein (to detect tdTOM) (Rockland Immunochemicals, Gil-
bertsville, PA), rabbit-nesfatin (Phoenix Pharmaceuticals, Bur-
lingame, CA), mouse -tyrosine hydroxylase (TH) (Chemicon,
Temecula, CA), goat -choline acetyltransferase (ChAT; Milli-
pore, Billerica, MA), or rabbit -nitric oxide synthase (nNOS;
Immunostar, Hudson, WI). Sections were washed in PBS then
incubated in blocking buffer containing appropriate secondary
antibody (1/1000, Alexa Fluor; Molecular Probes, Eugene, OR)
for 1 h. Sections were mounted onto microscope slides and cov-
erslipped in an aqueous mounting medium (Vectastain; Vector
Laboratories, Burlingame, CA). Double-labeled cells were re-
corded if both fluorescent signals were present in the same cell
and each alone clearly defined a cellular shape.
Leptin-induced phosphorylated signal transducer
and activator of transcription 3 (pSTAT3)
immunohistochemistry
LepRb-Cre-EYFP and LepRb-Ires-Cre::tdTOM mice were
injected during the light cycle with 5 mg/kg mouse recombinant
leptin (ip) (Merck, Whitehouse Station, NJ) and food removed.
Animals were perfused 2 h later and the tissue processed as de-
tailed above. pSTAT3 immunohistochemistry using a rabbit an-
ti-pSTAT3 antibody (1/250; Cell Signaling Technology, Dan-
vers, MA) was conducted as previously described (3). Sections
were then extensively washed in PBS and processed for either
GFP or red fluorescent protein immunofluorescence histochem-
istry as described above.
Dual in situ hybridization and
immunohistochemistry
In situ hybridization was conducted as previously described
(14). Radiolabeled riboprobes specific to the mRNA sequences
of PPG (15), cocaine- and amphetamine-regulated transcript
(CART) (15), CCK (16), glutamate decarboxylase-67 (GAD67)
(17), brain-derived neurotrophic factor (BDNF; designed to
1172–1467 bp of the mouse cDNA), and prolactin-releasing
peptide (PrRP; designed to thewholemouse coding region) were
used to detect gene expression. Linearized recombinant plasmids
were subjected to in vitro transcription with a T7 RNA poly-
merase (Ambion Inc., Austin, TX) in the presence of 35S-labeled
UTP. cRNA riboprobes were diluted to 2  107 cpm/ml in hy-
bridization solution. Tissue was washed in PBS before com-
mencement of the immunohistochemistry protocol. Sections
were treated for 30min in 0.3%H2O2 in PBS, rinsed in PBS, and
blocked in0.5%BSA/0.5%TritonX-100 inPBS for 1h. Sections
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were incubated in blocking buffer containing goat -GFP anti-
body (1/1000; Abcam) overnight. Sections were washed in PBS
and a biotinylated donkey antigoat secondary antibody (Vector
Laboratories) applied at 1/1000 in blocking buffer for 1 h. Sec-
tions were then washed in PBS and incubated for 1 h in Vec-
taStain ABC reagent and chromogenic detection conducted
using 3,3-diaminobenzidine reagent (Vector Laboratories). Sec-
tions were mounted onto microscope slides and air dried. Slides
were dipped in photographic emulsion (Kodak, Rochester, NY)
and stored at 4 C for 2 wk before being developed in D-19 de-
veloper and fixer (Kodak). Double-labeled cells were recorded if
GFP-positive cell bodies contained overlying black grains that
were in a quantity greater than three times background and con-
formed to the shape of theGFP-immunoreactive (IR) cell bodies.
Analysis
Sections containing NTS were assigned a bregma level and
boundaries of theNTS delineated based on neuro-architecture and
theMouse BrainAtlas (18). The number of LepRb-expressing neu-
rons, neurochemically defined neurons, and double-labeled neu-
rons fallingwithin the defined regionswere counted and expressed
as a percentage of total LepRb-expressing neurons in that section.
Data are presented as mean SEM (n 3–4 per study).
Results
LepRb NTS subregional localization and validation
of LepRb reporter lines
Two reporter lines, LepRb-Ires-Cre::tdTOM and LepR-
Cre-EYFP,wereusedtoperformacharacterizationofLepRb
expression within the NTS. The overall distribution of td-
TOM-IR and GFP-IR (EYFP) cells was consistent in both
lines and extended across the rostal-caudal extent of the
NTS, although in general, the LepR-Cre-EYFP line labeled
more cells than the LepRb-Ires-Cre::tdTOM line (Fig. 1). In
both lines, LepRb-expressing neurons within the NTS were
most abundant at the level of the area postrema. Reporter
detection of LepRb-expressing cells was also found within
most subdomains of the NTS but was highest in the medial
and, toa lesserextent,ventrolateral regions; thecommissural
portion was typically devoid of labeled cells.
To validate reporter expression with endogenous
LepRb, we mapped and quantified colocalization of td-
TOM-IR and EYFP-IR with leptin-induced pSTAT-IR.
Colocalization of tdTOM-IR and GFP-IR with pSTAT3-IR
also revealed a high degree of consistency between both re-
porter lines.Within a discrete subregion of theNTS, the ros-
tral portion, very few tdTOM-IR or GFP-IR neurons cola-
beled with pSTAT3-IR (Fig. 1; bregma 6.84 mm,
tdTOM-IR 6.3  2.6% and GFP-IR 4.1  2.9%; bregma
7.20 mm, tdTOM-IR 10.0  1.4% and GFP-IR 25.0 
6.0%), highlighting a localized site of potential ectopic re-
porter expression or LepRb neurons of lower sensitivity to
exogenous leptinadministration.However, in the remainder
of the NTS (bregma 7.56 mm to the caudal extent of the
NTS), pSTAT3-IRwas detected in 70.11.9% tdTOM-IR
neurons and80.11.9%ofGFP-IRneurons (Fig. 1). These
data support the utility of both reporter lines in LepRb char-
acterization in the NTS including bregma7.56 mm to the
caudal extent, where the majority of NTS LepRb reside and
known energy balance-associated neuromodulators are also
expressed.
Identification of first-order NTS leptin-responsive
neurons
To identify the first-order energy balance-associated
NTS neurons directly modulated by leptin, we analyzed
the chemical phenotype of LepRb-expressing neurons
FIG. 1. Neuroanatomical distribution and validation of transgenically
labeled LepRb-expressing neurons of the NTS. LepRb-expressing
neurons in LepRb-Ires-Cre::tdTOM and LepRb-Cre::EYFP mice were
found across the rostral-caudal extent of the NTS with the
preponderance being localized to the NTS at the level of the area
postrema. The validity of reporter expression in each line was
confirmed via leptin-induced pSTAT3-IR and colocalization with
tdTOM- or EYFP-expressing neurons. Each dot ( ) represents five
reporter-labeled neurons negative for pSTAT3 and each star () five
reporter-labeled neurons positive for pSTAT3. AP, Area postrema; cc,
central canal; 4v, fourth ventricle.
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(bregma7.56 mm to the caudal extent of the NTS). In
light of leptin’s regulation of arcuate nucleus POMC
andNPY neurons (10), we examined whether the NTS repre-
sents another site of functional convergence for these systems.
To facilitate analysis, the LepRb-Ires-Cre::tdTOM line was
crossedwiththePOMC-EGFPorNPY-GFPlines.Weobserved
that26.07.8%ofLepRb-Ires-Cre::tdTOM-IRneuronswere
colocalizedPOMC-EGFP-IRcellswithinthemedialNTSatthe
level of the area postrema (Fig. 2A and Table 1). In contrast,
LepRb neurons did not colocalize with cells expressing NPY-
GFP-IR (Fig. 2B).
Additional neurochemical profiling demonstrated the
lack of LepRb in several other NTS neuronal populations
implicated in energy balance, including those expressing
TH (a catecholamine marker, Fig. 2C), nesfatin (Fig. 2D),
ChAT (a cholinergic marker, Fig. 2E), nNOS (Fig. 2F),
PrRP (Fig. 2G), GAD67 [a -aminobutyric acid (GABA)-
FIG. 2. Neurochemical profiling of LepRb-expressing cells of the caudal NTS. A–F, Double-immunofluorescent analysis of LepRb-expressing
neurons in compound LepRb-Ires-Cre::tdTOM/POMC-EGFP and LepRb-Ires-Cre::tdTOM/NPY-GFP mice revealed colocalization of LepRb-expressing
neurons (red) with POMC-expressing (green; A) but not NPY-expressing (green; B) neurons of the NTS. Immunohistological analysis in
LepRb-Cre::EYFP mice also demonstrated these cells to be negative for TH (C), nesfatin (D), ChAT (E), nNOS (F). G–L, Dual-immunohistological and
in situ hybridization analysis demonstrated the absence of LepRb coexpression (brown cytoplasmic stain) with PrRP (G), GAD67 (H), BDNF (I), or
CART (J) mRNA (black grains). However, LepRb neurons were found to express PPG/GLP1 (K) and CCK (L) mRNA. M–O, Population analysis of NTS
LepRb-expressing neurons demonstrated that POMC-EGFP neurons did not express PPG/GLP1 (M) or CCK (N) but that a proportion of PPG/GLP1-
YFP NTS neurons also exhibited CCK expression (O). Arrows represent single-labeled cells and arrowheads colocalized cells. cc, Central canal. Scale
bar in A applies to A–I and represents 50 m. Scale bar in A inset applies to insets in K, L, and O and represents 25 m.
TABLE 1. Quantification of LepRb-expressing NTS
neurons
Bregma 7.56 7.64 7.76 7.92 Total %
POMC 14/40 5/18 3/18 0/11 20/77 26
PPG 22/40 18/22 7/14 5/7 52/83 62
CCK 18/42 12/26 4/10 6/13 40/91 44
The average number of LepRb-expressing neurons positive for POMC,
PPG, or CCK per total LepRb within that level of the NTS (n  3–4).
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ergicmarker, Fig. 2H], BDNF (Fig. 2I), or CART (Fig. 2J).
In contrast, and located more caudally than the POMC/
LepRb population, 62.6 6.4% of LepRb-Cre::EYFP-IR
neurons were found to express PPGmRNA [or glucagon-
like peptide-1 (GLP1)] (Fig. 2K and Table 1), and 43.9
1.4% expressed CCK mRNA (Fig. 2L and Table 1).
We further characterized these three populations of
LepRb-expressing NTS neurons to determine whether
they represent distinct or overlapping populations. We
assessed PPG/GLP1 coexpression with POMC through
PPG mRNA labeling in the POMC-EGFP line (Fig. 2, M
andN) and examinedCCKcoexpressionwith POMCand
PPG/GLP1 using CCK mRNA expression in the POMC-
EGFP line (Fig. 2N) or PPG-YFP (Fig. 2O) line. We ob-
served no overlap between POMC-EGFP and either PPG/
GLP-1 or CCK, suggesting that POMC-EGFP neurons
represent a discrete subpopulation of LepRb NTS neu-
rons, although we observed some overlap between PPG/
GLP1 and CCK.
Effects of leptin deficiency on leptin-responsive
NTS neuropeptide expression
The significance of leptin signaling to the physiological
function of these three neuronal populations was investi-
gated through the assessment of gene expression in con-
genitally leptin-deficient Ob/Ob mice. Radioactive in situ
hybridization followed by densitometry analysis demon-
strated a substantial increase of PPGmRNA (Fig. 3, D–F;
100%, t  3.9, P  0.05) and CCK mRNA (Fig. 3, G–I;
346%, t 3.6, P 0.05) but not POMC mRNA (Fig. 3,
A–C) specifically within the NTS of Ob/Ob mice com-
pared with wild-type controls. These data reveal that loss
of leptin tone inOb/Obmice is important to the transcrip-
tional regulation of PPG/GLP1 andCCK, but not POMC.
Discussion
Leptin action via LepRb-expressing NTS neurons plays a
crucial role in the physiological regulation of energy bal-
ance (6, 8, 9). In an effort to define the neurotransmitter/
neuropeptide content of first-order LepRb neurons in this
brain region, we performed a comprehensive neurochem-
ical profile of NTS LepRb neurons. Using multiple trans-
genic reporter lines to facilitate analysis, we report LepRb
colocalization with POMC-EGFP neurons, with neurons
that express PPG/GLP1 and with neurons that express
FIG. 3. The effect of leptin deficiency on NTS LepRb neuron-associated neuropeptide expression. Quantitative radioactive in situ hybridization
autoradiographical analysis of POMC (A–C), PPG/GLP1 (D–F), and CCK (G–I) mRNA expression in leptin-deficient Ob/Ob mice. Loss of leptin tone
had no effect on NTS POMC expression but resulted in a significant up-regulation of PPG/GLP1 and CCK expression. C, F, and I, Data are
presented as mean  SEM, Student’s t test. *, P  0.05.
4604 Garfield et al. LepRb Neurons of the NTS Endocrinology, October 2012, 153(10):4600–4607
CCK but not with other energy balance-associated pop-
ulations that contain NPY, BDNF, CART, nesfatin, cat-
echolamines, GABA, acetylcholine, PrRP, or nNOS.
Validation analysis of the LepRb-reporter lines re-
vealed a high degree of colocalization with endogenous
LepRb in all regions of theNTS except the rostral portion.
This identifies either a discrete rostral site of ectopic ex-
pression in both reporter lines or endogenous LepRb that
are less sensitive to exogenous leptin administration. Re-
gardless, none of the rostral reporter-labeled cells coex-
pressed the chemical markers investigated here. We con-
clude that the data presented provide insight into the
mediators that directly respond to leptin in the NTS in the
regulation of energy balance.
Consistentwith the present results, the detection of lep-
tin-stimulated STAT3 phosphorylation (a marker of
LepRb activation) has been used previously to indicate the
absence of LepRb expression on neurochemically defined
NTS neurons, such as those expressing CART (19), TH/
catecholamines (19), and GABA (20), and their presence
on glutamatergic (20) and POMC (19) neurons. Our re-
sults demonstrating the lack of LepRb in NTS NPY, nes-
fatin, acetylcholine, nNOS, and BDNF neurons are novel.
The lack of LepRb in NTS BDNF neurons is unexpected
given that NTS BDNF expression is influenced by nutri-
tional state and exogenous leptin administration (21).
Thus, leptin regulation of NTS BDNF is likely to be indi-
rect, perhaps via local projections from neighboring NTS
LepRb neurons. That we find no support for LepRb ex-
pression onPrRPneurons is in contrast to previous studies
(22, 23). It is possible that the approximately 7%ofmouse
NTS PrRP neurons reported to exhibit leptin-induced
pSTAT3-IR (22) are not represented by the reporter lines
used. However, evidence that NTS PrRP neurons are also
catecholaminergic (23) supports our observations, be-
cause LepRb-expressing neurons have been demonstrated
to be TH negative (19) (Fig. 2C).
Due to low endogenous POMC expression in the NTS,
NTSPOMCneurons are typically reliably detected only at
the single-cell level through transgenic methods of vi-
sualization. The combined use of POMC-EGFP and
LepRb-Ires-Cre::tdTOM reporter alleles thus facilitated
the direct detection of NTS POMC-EGFP/LepRb colocal-
ization. Themajority of EGFP/tdTOM-positive cells were
localized to theNTSwhere approximately 26%ofLepRb-
expressing neurons were POMC-EGFP positive. These
findings are consistent with previous observations of lep-
tin-induced pSTAT3-IR in POMC-EGFP cells (19) but are
in contrast to a report of a lack of leptin action in NTS
POMC neurons using a Cre-driven POMC reporter line
(24), now known to also label nonfated POMC cells (25).
However, we demonstrate that leptin deficiency does not
alter endogenous POMC mRNA expression in Ob/Ob
mice. The very low expression of POMC mRNA in the
NTS suggests that POMC-derived peptides may not sig-
nificantly contribute to neurotransmission by the POMC-
EGFP/LepRb neurons, consistent with the lack of regula-
tion of NTS POMC mRNA by leptin deficiency or
peripheral leptin administration (24). Thus, although a
proportion of NTS LepRb neurons are coexpressed with
POMC-EGFP, and these are clearly distinct from PPG/
GLP-1 and CCK neurons, the relevant leptin-regulated
neuropeptides and/or neurotransmitters in the LepRb/
POMC-EGFP neurons of the NTS is unclear.
A second population of leptin-responsive neurons ex-
press PPG/GLP1 within the lateral portion of the medial
NTS, consistent with a previous report (26–28). Our
transgenic approach toLepRbvisualization suggests PPG/
GLP1 neurons represent the largest neurochemically de-
fined subpopulation of LepRb-expressing cells, account-
ing for approximately 60% of NTS LepRb. This
observation is consistent with recent studies of NTS PPG/
GLP1 cells that suggest them to be the primary effector of
NTS LepRb-regulated energy balance in mice (8). Con-
cordantly, NTS PPG mRNA expression was significantly
increased in Ob/Ob mice, corroborating previous obser-
vationsmade in the obeseZucker rat (a ratmodel of leptin
insufficiency), which also exhibits elevated NTS PPG ex-
pression (29).
As peripherally synthesized satiety factors, CCK and
leptinact synergistically at vagal afferents to suppress food
consumption (1). However, in addition to its synthesis in
I-cells of the small intestine, CCK is abundantly expressed
within the brain where it serves as a peptidergic neu-
rotransmitter.We now report that approximately 40%of
NTSLepRb neurons express CCK; these neurons are clus-
tered caudal to the area postrema, in a distribution that
partially overlaps with the distribution of PPG/GLP-1
LepRb neurons. Furthermore, NTS CCK expression is in-
creased in the absence of leptin signaling. Although pre-
vious analyses of CCK mRNA levels in Ob/Ob whole
brain failed to identify significant changes (1, 30), more
discrete neuroanatomical investigation nowdemonstrates
marked up-regulation in the Ob/Ob NTS. That we ob-
served no overt changes in CCK expression in any other
site of the Ob/Ob brain (data not shown) suggests that
NTS CCK neurons may be of particular relevance to en-
ergyhomeostasis and that leptindirectly influences central
CCK function.
The finding that LepRb neurons expressing PPG/
GLP-1 and CCK are codistributed and that a proportion
of PPG/GLP-1 neurons contain CCK suggests that a sub-
population of NTS LepRb PPG/GLP-1 neurons coexpress
CCK. Indeed, because NTS POMC-EGFP neurons (26%
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of NTS LepRb neurons) do not express either PPG/GLP-1
or CCK (62 and 44% of NTS LepRb neurons, respec-
tively), some overlap between LepRb PPG/GLP-1 and
LepRb CCK neurons must exist.
Although the data presented here consolidate and ex-
pand upon the understanding of leptin-engaged NTS cir-
cuits, it is possible that the absenceofLepRbexpressionon
CART,BDNF,GABA,orPrRPneuronsmaybe influenced
by the sensitivity of the in situ hybridization method.
However, unlike previously employed PCR techniques, in
situhybridizationaffords neuroanatomical specificity, en-
abling a highly focused assessment of NTS LepRb neuron
populations.
The cellular heterogeneity of the NTS raises questions
as to theneurochemical identifyof theneurons responsible
for promoting the physiological response to LepRb acti-
vation and the pathological consequences of LepRb inac-
tivation. However, until now, no comprehensive neuro-
chemical characterization of these neurons has been
undertaken. Here we demonstrate this population to be
comprised of POMC-, PPG/GLP1-, and CCK-expressing
cells. These data provide valuable insight into the brain-
stem pathways through which leptin’s energy balance
functions are implemented.
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